T-cells

Amgen's tarlatamab BiTEs at small cell lung cancer in brief readout
Fierce Biotech
Thu, 08/3/23 - 06:37 pm
Amgen
tarlatamab
small cell lung cancer
T-cells
60 Scientists Sign Letter Petitioning FDA for T Cell Recognition
BioSpace
Sat, 04/23/22 - 03:47 pm
FDA
T-cells
COVID-19
vaccines
Plant-based biopharma firm iBio licenses novel antibody targeting regulatory T cells
Biopharma Reporter
Thu, 09/2/21 - 09:25 am
iBio
anti-CD25 antibodies
T-cells
Next-gen T-cell cancer player Neogene raises $110M with help from some big-name players
Fierce Biotech
Mon, 09/14/20 - 10:55 am
Neogene Therapeutics
T-cells
Two papers open door to T cell brain entry for glioblastoma therapy
BioCentury
Thu, 09/6/18 - 11:44 am
T-cells
glioblastoma
brain cancer
Nature
Adaptimmune Completes Transition of Pioneering T-Cell Therapy to GSK – Will Receive $27 Million Payment
CP Wire
Tue, 07/24/18 - 10:54 am
Adaptimmune
GSK
GSK3377794
T-cells
Roche study finds cancer 'Velcro' that halts T-cell attack
Reuters
Sun, 12/10/17 - 09:51 am
Roche
T-cells
cancer
drug development
Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer
Endpoints
Wed, 10/4/17 - 11:23 am
Amgen
Immatics
T-cells
Adaptimmune gets a partial hold on pivotal T-cell study, but it seems OK to breathe now
Endpoints
Thu, 08/4/16 - 09:56 am
Adaptimmune
T-cells
myxoid round cell liposarcoma
CAR-T
cancer immunotherapy
Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech
Fierce Biotech
Tue, 06/9/15 - 12:00 pm
Celegene
Lycera
M&A
cancer
T-cells